You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE excipient

Market Dynamics and Financial Trajectory for Sodium Phosphate, Dibasic, Heptahydrate

Last updated: January 23, 2026

Summary

Sodium Phosphate, Dibasic, Heptahydrate (SPDH) holds a significant position within the pharmaceutical excipients industry due to its multifaceted applications in pharmaceuticals, food, and water treatment. The global market for SPDH exhibits steady growth driven by increasing pharmaceutical formulations, rising health consciousness, and expanding industrial applications. This report examines the current market landscape, key drivers, competitive environment, and financial trends, providing essential insights for stakeholders and investors aiming to navigate this niche.


Market Overview: Definition and Applications

Chemical identity:

Property Specification
Name Sodium Phosphate, Dibasic, Heptahydrate (Na₂HPO₄·7H₂O)
CAS Number 10039-32-4
Molecular Weight 268.07 g/mol

Primary applications include:

  • Pharmaceuticals: Buffering agent, excipient in tablets, suspension stabilizer
  • Food Industry: pH regulator, leavening agent
  • Water Treatment: pH adjustment, corrosion control
  • Other Industrial Uses: Laboratory reagents, bleaching agents

Current Market Size and Forecast

Year Estimated Global Market Size (USD billion) CAGR (Compound Annual Growth Rate) Key Sources
2022 $0.35 4.2% [1], [2]
2023 $0.36 4.0% Forecast
2028 $0.45 4.8% Forecast

The market is projected to grow from USD 350 million in 2022 to approximately USD 450 million by 2028.


Key Market Drivers

1. Expanding Pharmaceutical Applications

The pharmaceutical industry constitutes approximately 60% of spacers into the SPDH market, emphasizing its role as a buffering and stabilizing excipient. Governments and industry regulations favor excipients with high purity standards, bolstering demand.

2. Growing Food Industry Adoption

SPDH serves as a pH regulator and leavening agent, driven by rising confectionery, baking, and processed food production, especially in Asia-Pacific regions.

3. Water Treatment Market Expansion

Growing urbanization and industrialization increase the need for pH adjustment chemicals, including SPDH, in municipal and industrial water treatment.

4. Regulatory Trends

Stringent regulatory standards for pharmaceutical excipients promote the use of high-quality, well-characterized compounds like SPDH, favoring manufacturers with GMP-compliant production facilities.

5. Rising R&D expenditure

Investment in pharmaceutical R&D leads to the development of new formulations and injectable drugs, which require buffering agents like SPDH.


Competitive Environment

Company Name Market Share (%) Production Capacity (tons/year) Key Strategies Notable Products
Fosfa Group 30% 20,000 Vertical integration, R&D focus PUREtech™ series
Innophos Holdings, Inc. 25% 15,000 Strategic acquisitions Sodium Phosphate Series
Hangzhou Chemphil 15% 10,000 Geographic expansion ChemPhilteene™
Other Smaller Players 30% - Niche formulations Varied

The industry is moderately consolidated, with the top 2 players controlling approx. 55% market share.


Pricing Trends and Financial Performance

Parameter 2022 Data 2023 Projection Notes
Average Price per Kg (USD) $1.50 $1.52 – $1.58 Slight upward trend due to raw material costs
Gross Margin 20-25% 22-27% Efficiency gains offset raw material inflation
Operating Margins 10-15% 12-18% Lean manufacturing and economies of scale

Raw Material Cost Influences

The key raw materials include sodium hydroxide and phosphoric acid. Price volatility in feedstock chemicals influences broader product pricing.


Regional Market Insights

Region Market Share (%) Growth Drivers Challenges
Asia-Pacific 40% Rapid industrialization, food & pharma growth Regulatory hurdles, quality standards
North America 25% Mature pharma sector, water treatment demand Stringent regulations, market saturation
Europe 20% Eco-friendly regulations, R&D investments High raw material costs
Rest of World 15% Emerging economies, food processing Infrastructure limitations

Regulatory Framework and Policy Impact

  • Pharmaceutical: US FDA and EMA guidelines specify rigorous purity standards for excipients.
  • Food: EU Regulation 1169/2011 mandates the safety of food additives including phosphate derivatives.
  • Water Treatment: Compliance with EPA standards in the US and similar agencies worldwide impacts usage.

Comparison with Other Phosphate-Based Excipients

Compound Uses Market Share (%) Key Differentiators
Monobasic Sodium Phosphate Buffering in IV fluids, laxatives 35% Solubility profile, ease of formulation
Tribasic Sodium Phosphate Detergents, water treatment 20% pH buffer strength
Dibasic Sodium Phosphate (Heptahydrate) Food & pharma excipient, water treatment 45% High solubility, buffering capacity

SPDH's unique hydrate form influences dissolution rate and buffering capacity, hence its preferred uses.


Financial Trajectory and Investment Opportunities

  • Manufacturing Investment: Upscaling production capacity aligned with rising demand can leverage economies of scale.
  • R&D Focus: Developing formulations with higher bioavailability and stability could command premium pricing.
  • Regulatory Compliance: Ensuring adherence to evolving standards provides competitive advantage and access to high-value markets.

Deep-Dive: Market Challenges and Risks

Challenge Impact Mitigation Strategy
Raw material price volatility Margins under pressure Long-term supply contracts
Stringent regulations Market entry barriers for new entrants Investment in compliance and quality assurance
Competition from synthetic alternatives Potential commoditization Innovation in formulation and application niche

Conclusion: Market Outlook and Strategic Recommendations

The future trajectory of Sodium Phosphate, Dibasic, Heptahydrate remains favorable with an expected CAGR of 4.6%-4.8% over the next five years. Key drivers include expanding pharmaceutical formulations and water treatment needs, especially in emerging markets.

Strategic focus areas for industry stakeholders:

  • Enhance supply chain resilience with diversified sourcing of raw materials.
  • Invest in R&D to develop high-purity, value-added formulations.
  • Expand regional footprint in Asia-Pacific and Latin America.
  • Ensure regulatory compliance to access high-growth markets and premium segments.

Key Takeaways

  • The global SPDH market is valued at approximately USD 350 million in 2022, projected to reach USD 450 million by 2028.
  • Industry growth is driven primarily by pharmaceutical and water treatment sectors.
  • Major players hold over 50% of the market share, with opportunities in capacity expansion and R&D.
  • Fluctuations in raw material costs and regulatory landscapes represent significant risks.
  • Emerging markets offer growth potential, with the Asia-Pacific region being a primary focus.

FAQs

1. What are the main factors influencing prices for Sodium Phosphate, Dibasic, Heptahydrate?
Prices are chiefly affected by raw material costs (phosphoric acid, sodium hydroxide), quality standards, and regulatory compliance costs. Supply chain disruptions can also cause volatility.

2. Which industries are the primary consumers of SPDH?
Pharmaceutical manufacturing (~60%), food processing (~25%), and water treatment (~15%) are the primary industries.

3. How does regulation impact the market?
Strict regulations for pharmaceutical and food grade excipients enforce high purity standards, incentivizing quality improvements and compliance investments but potentially creating barriers for new entrants.

4. What geographic regions are experiencing the fastest growth?
The Asia-Pacific region is exhibiting the highest CAGR driven by rapid industrialization, urbanization, and expanding healthcare infrastructure.

5. What are the prospects for innovation in this market?
Opportunities exist in developing water-soluble variants, biodegradable formulations, and hybrid excipients that improve bioavailability or stability.


References

[1] Market Research Future, "Global Sodium Phosphate Market Report," 2022.
[2] Grand View Research, "Phosphates Market Size & Share," 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.